Advancing ADC Characterization: SECBased Native DAR and Drug Distribution Analysis Using Multi-Reflecting TOF-MS and INTACT Mass Application
Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Accelerating GLP-1 Development with High- Throughput LC-MS Using the BioAccord™ LC MS System and the INTACT Mass Application
Applications
| 2025 | Waters
LC/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Analysis of Free Inositol Stereoisomers in Dietary Supplements by Hydrophilic Liquid Chromatography using the Arc™ Premier System and ACQUITY™ QDa™ II Mass Detector
Applications
| 2025 | Waters
LC/MS, LC/SQ
Instrumentation
LC/MS, LC/SQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Assessment of Biosimilarity in mAb-based Therapeutics Using SEC-MALS
Applications
| 2025 | Waters
GPC/SEC
Instrumentation
GPC/SEC
Manufacturer
Waters
Industries
Pharma & Biopharma
Quantification of Semaglutide in Human Plasma Using a Benchtop Multi-reflecting Time-of-Flight Mass Spectrometer
Applications
| 2025 | Waters
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma, Clinical Research
Ensuring Safe and Affordable Drinking Water in the United Arab Emirates (UAE) Market Through Per- and Polyfluoroalkyl Substances (PFAS) Testing using the ACQUITY™ UPLC™ I-Class and Xevo™ TQ Absolute System